NCT01617070 - Effects of Kuvan on Melatonin Secretion | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Phenylketonuria (PKU)

Interventions

DRUG

Kuvan

Dosed at 20 mg/kg; PO; Phase 3, Phase 4

DIETARY_SUPPLEMENT

Large Neutral Amino Acid Therapy

Dosed by weight: weight x .5 = total tablets per day; PO; Phase 1, Phase 4; taken with food

Trial Locations (1)

Keck School of Medicine, Clinical Trials Unit at Keck Medical Center of USC, Los Angeles